LG, AstraZeneca to co-market Vimovo in Korea

Published: 2012-07-26 06:56:00
Updated: 2012-07-26 06:56:00
LG Life Sciences (LGLC) and AstraZeneca Korea (AZK) Tuesday announced that the two companies have signed an agreement to co-market AZK’s Vimovo tablets from next month in Korea.

Vimovo contains a combination of esomeprazole and naproxen. Naproxen is a nonsteroidal anti-inflammatory drug (NSAID...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.